SEC Filing Summary: Supernus Pharmaceuticals, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K Current Report was filed by Supernus Pharmaceuticals, Inc. on March 27, 2015, covering events occurring on March 26, 2015. The company is incorporated in Delaware and is based in Rockville, Maryland.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate governance event.
Material Changes
The primary material change reported is the departure of a senior officer:
- Individual: Jones W. Bryan, Ph.D.
- Former Title: Vice President of Business Development.
- Effective Date: April 9, 2015.
- Reason: Resignation to pursue other interests.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, management commentary on operations, specific risks, contingencies, or unusual items beyond the officer departure.
Investor Verification Checklist
- Confirm the appointment of a successor for the Vice President of Business Development role.
- Review the company's pipeline and business development strategy to assess the impact of this departure.
- Check subsequent filings for any changes in the company's strategic direction related to business development.